subject area of
- A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer Journal Articles
- Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis Journal Articles
- Androgen‐dependent regulation of medium and long chain fatty acids uptake in prostate cancer Journal Articles
- Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review Journal Articles
- Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial Journal Articles
- Breast Cancer Consensus Meetings: Vive la Difference? Journal Articles
- Cancer Care Ontario Guideline Recommendations for Hormone Receptor Testing in Breast Cancer Journal Articles
- Chemoprevention: Drug pricing and mortality Journal Articles
- Clusterin knockdown using the antisense oligonucleotide OGX‐011 re‐sensitizes docetaxel‐refractory prostate cancer PC‐3 cells to chemotherapy Journal Articles
- Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17 Journal Articles
- Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination Journal Articles
- Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancer Journal Articles
- Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions Journal Articles
- Immuno-gene therapy of established prostate tumors using chimeric receptor-redirected human lymphocytes. Journal Articles
- Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: A mechanistic model supporting prevention strategies Journal Articles
- Overexpression of vimentin: role in the invasive phenotype in an androgen-independent model of prostate cancer. Journal Articles
- PREDICTORS OF PATHOLOGICAL STAGE BEFORE NEOADJUVANT ANDROGEN WITHDRAWAL THERAPY AND RADICAL PROSTATECTOMY Journal Articles
- Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer. Journal Articles
- Plasma osteopontin Journal Articles
- Potential involvement of mt1 receptor and attenuated sex steroid‐induced calcium influx in the direct anti‐proliferative action of melatonin on androgen‐responsive LNCaP human prostate cancer cells Journal Articles
- Preparation and Evaluation of Carborane Analogues of Tamoxifen Journal Articles
- Systematic Review on Hormone Receptor Testing in Breast Cancer Journal Articles
- Targeting prostate cancer with HTI‐286, a synthetic analog of the marine sponge product hemiasterlin Journal Articles
- Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor Journal Articles
- Towards optimal endocrine therapy for hormone-sensitive breast cancer: Initial versus sequential adjuvant aromatase inhibition Journal Articles